BMK methyl glycidate is primarily used in the synthesis of various pharmaceuticals and organic compounds. It serves as a key intermediate in the production of certain medications, particularly those related to central nervous system disorders. Additionally, it is utilized in research and development for creating novel chemical entities with potential therapeutic applications. Its role in organic synthesis also extends to the production of fine chemicals and specialty materials, contributing to advancements in industrial chemistry and material science.